Closing Bell: Fennec Pharmaceuticals Inc down on Thursday (FRX)

Today in trading, Fennec Pharmaceuticals Inc shares closed at $8.86 after opening the day at $9.13. Intraday prices ranged from a low of $8.73 to a high of $9.13.

The price decreased -2.64 percent from the previous day's close of $9.10.

Today across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Fennec Pharmaceuticals Inc has listed on the Toronto Stock Exchange (TSX) under the ticker FRX.

A total of 1,400 shares was traded during the session, with total trades of 14, while having an average volume of 2,370 over 5 days.

The TSX market on the whole today saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, FRX.TO has traded as high as $15.43 (December 28,2023) and low as $7.80 (July 05,2024). Moreover, the shares have shrunken -23.95 percent in the last year, while they have shrunken -41.56% year-to-date.

Following today's trading, Fennec Pharmaceuticals Inc has a market capitalization of $248.63 million on a float of 27,322 shares outstanding. Its annual EPS is $0.04.

Fennec Pharmaceuticals Inc is a None company headquartered in Research Triangle Park, USA.

Currently, Fennec Pharmaceuticals Inc's consensus rating is "Strong Buy" based on 6 analysts according to Zacks. From those 6 analysts, 6 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..